Shmuel Hess

CIK: 0002085305

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (60.0%)

Position reduction

Option Exercises (M)2 (40.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MDWD

MediWound Ltd.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

MDWD
MediWound Ltd.
Aug 27, 2026
Sale(S)
Direct
2K shares at avg. $12.72$25K
MDWD
MediWound Ltd.
Aug 27, 2026
Sale(S)
Direct
2K shares at avg. $13.13$26K
MDWD
MediWound Ltd.
Aug 27, 2026
Exercise(M)
Stock Option (right to buy ordinary shares)
Direct
11K shares-
MDWD
MediWound Ltd.
Aug 26, 2026
Sale(S)
Direct
1.9K shares at avg. $13.00$24K
MDWD
MediWound Ltd.
Aug 26, 2026
Exercise(M)
Stock Option (right to buy ordinary shares)
Direct
5K shares-

		Type	Shares	Price		Ownership
Aug 27, 2026	MDWD MediWound Ltd.	Sale(S)	1,979	$12.72	$25,173	Direct
Aug 27, 2026	MDWD MediWound Ltd.	Sale(S)	1,979	$13.13	$25,976	Direct
Aug 27, 2026	MDWD MediWound Ltd.	Exercise(M) Stock Option (right to buy ordinary shares)	11,000	-	-	Direct
Aug 26, 2026	MDWD MediWound Ltd.	Sale(S)	1,865	$13.00	$24,245	Direct
Aug 26, 2026	MDWD MediWound Ltd.	Exercise(M) Stock Option (right to buy ordinary shares)	5,000	-	-	Direct

1-5 of 5 transactions

About Hess Shmuel

Hess Shmuel (SEC CIK 0002085305) files insider reports with the SEC as COO & Chief Commercial Officer of MediWound Ltd. (MDWD).

Signal8 holds 2 ownership filings by Hess Shmuel (1 Form 3, 1 Form 4), filed between Mar 18, 2026 and Aug 28, 2026. Those filings report 5 transactions, from Aug 26, 2026 to Aug 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hess Shmuel's filings is in YAVNE.

Recent filings by Hess Shmuel

Aug 27, 2026: Open-market sales of MDWD shares (2 lines, Form 4, code S).
Aug 27, 2026: Option exercise of MDWD derivative securities (Form 4, code M).
Aug 26, 2026: Open-market sale of MDWD shares (Form 4, code S).
Aug 26, 2026: Option exercise of MDWD derivative securities (Form 4, code M).

Other insiders filing for MediWound Ltd. (MDWD)

Rubinstein Samuel, Director
SHAMIR NACHUM, Director
Fox David Morton, Director
Driver Vickie Rae, Director
Luxenburg Kalfon Hana, Chief Financial Officer
Klinger Ety, Chief Medical Officer

How to read Form 4 transaction codes